Peak6 Investments LLC Eagle Pharmaceuticals, Inc. Transaction History

Peak6 Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$53.25 - $59.98 $19,436 - $21,892	-365 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $154,325 - $193,527	-3,311 Reduced 90.07%	365 $20,000
Q1 2019 May 15, 2019	SELL	$38.66 - $51.82 $171,070 - $229,303	-4,425 Reduced 54.62%	3,676 $186,000
Q4 2018 Feb 13, 2019	BUY	$36.72 - $67.73 $297,468 - $548,680	8,101 New	8,101 $326,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.